Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Yanagawa

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
International Journal of Immunopharmacology|January 1, 1989
Blocking of lymphocyte surface binding sites for the soluble suppressor factor by protein-bound polysaccharide, PSKT Toge, Y Yamaguchi, Y Kegoya, et al.
International Journal of Immunopharmacology|January 1, 1987
Reduction of suppressor cell activities of human peripheral blood lymphocytes by a streptococcal preparation, OK-432T Toge, H Yamada, K Aratani, et al.
The Japanese Journal of Surgery|March 1, 1990
Prospective randomized controlled study on bestatin in resectable gastric cancer--third reportM Niimoto, T Saeki, M Toi, et al.
The Japanese Journal of Surgery|January 1, 1982
Prognostic significance of lymphocyte proliferative responses to mitogens in gastric cancer patientsT Toge, M Oride, E Yanagawa, et al.
Gan No Rinsho. Japan Journal of Cancer Clinics|September 1, 1990
[The expression of NCC-ST-439, a tumor marker, in human breast cancer patients]E Miyahara, M Toi, T Wada, et al.
Gan|June 1, 1981
Combined treatment of syngeneic murine tumors and xenotransplanted human lung cancer by immunotherapy and radiotherapyH Terashima, K Yasumoto, E Yanagawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1986
[Development of cancer immunotherapy by a combination of biological response modifiers on the basis of their mechanism of action]T Toge, S Tomota, K Aratani, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 1, 1982
[The relationship between serum immunosuppressive acidic protein (IAP) and cellular immunity in the patients with gastric cancer]K Nakanishi, T Toge, S Hamamoto, et al.
American Heart Journal|August 1, 1991
Increased serum interleukin-6 in cardiac myxomaT Saji, E Yanagawa, H Matsuura, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1989
[Surgical stress and immunosuppression in cancer patients]T Toge, Y Kegoya, Y Yamaguchi, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
International Journal of Immunopharmacology|January 1, 1989
Blocking of lymphocyte surface binding sites for the soluble suppressor factor by protein-bound polysaccharide, PSKT Toge, Y Yamaguchi, Y Kegoya, et al.
International Journal of Immunopharmacology|January 1, 1987
Reduction of suppressor cell activities of human peripheral blood lymphocytes by a streptococcal preparation, OK-432T Toge, H Yamada, K Aratani, et al.
The Japanese Journal of Surgery|March 1, 1990
Prospective randomized controlled study on bestatin in resectable gastric cancer--third reportM Niimoto, T Saeki, M Toi, et al.
The Japanese Journal of Surgery|January 1, 1982
Prognostic significance of lymphocyte proliferative responses to mitogens in gastric cancer patientsT Toge, M Oride, E Yanagawa, et al.
Gan No Rinsho. Japan Journal of Cancer Clinics|September 1, 1990
[The expression of NCC-ST-439, a tumor marker, in human breast cancer patients]E Miyahara, M Toi, T Wada, et al.
Gan|June 1, 1981
Combined treatment of syngeneic murine tumors and xenotransplanted human lung cancer by immunotherapy and radiotherapyH Terashima, K Yasumoto, E Yanagawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1986
[Development of cancer immunotherapy by a combination of biological response modifiers on the basis of their mechanism of action]T Toge, S Tomota, K Aratani, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 1, 1982
[The relationship between serum immunosuppressive acidic protein (IAP) and cellular immunity in the patients with gastric cancer]K Nakanishi, T Toge, S Hamamoto, et al.
American Heart Journal|August 1, 1991
Increased serum interleukin-6 in cardiac myxomaT Saji, E Yanagawa, H Matsuura, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1989
[Surgical stress and immunosuppression in cancer patients]T Toge, Y Kegoya, Y Yamaguchi, et al.
Pageof 4